Kaylight Ltd. (MyCells)

www.my-cells.net ; www.my-cells.co.il

High-Tech Company

TECH VERTICALS

FemTech, Life Sciences, MedTech, Pharmaceuticals, Therapeutics

General Data

Sector	Biomed
Company Stage:	Initial Revenues
Established	2007
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

Kaylight developed MyCells® a revolutionary skin regenerating system. This autologous method uses your own blood to produce "Platelet Rich Plasma" (PRP), which is enriched with platelets, lymphocytes and growth factors. When the PRP is reintroduced into your body (via injection) it accelerates the normal healing process by stimulating collagen formation, revascularization and repair. This process brings long lasting tissue rejuvenation without side effects. PRP has been widely used for many years in plastic surgery, orthopedics, dentistry, and for both soft tissue implants and wound healing.

TECHNOLOGY

MyCells® is a method based on using Platelet Rich Plasma (PRP). PRP (Platelet Rich plasma) is a concentration of human platelets (PLT) in a small volume of plasma. PRP utilizes the patients own (autologous) PLT, derived from his/her blood.

Products and Phases

Product	Phase
MyCells	FDA Approved CE Approved ISO
MyCells® is a method based on using Platelet Rich Plasma (PRP). PRP (Platelet Rich plasma) is a concentration of human platelets (PLT) in a small volume of plasma. PRP utilizes the patients own (autologous) PLT, derived from his/her blood.

	TARGET MARKETS
	Dermatologists

	BUSINESS MODEL
	B2C

CONTACT INFO

Expand / Collapse All

Main Address: Ramat Hasharon, Israel

Address	18 Nahal Shorek St.
City	Ramat Hasharon
Country	Israel
Zip	4720251

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Ms. Tova Englard	CEO & Co-Founder
Dr. Livia Theodor	Scientific Director & Co-Founder

Last Updated:	abCDe
IVC Number:	abCDe